News
Clarametyx is advancing a Phase 1b/2a clinical trial of CMTX-101 for cystic fibrosis (CF)-associated infections following an interim analysis.
Awareness, community commitment at Dharamsala meet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback